Healthcare Industry News: VaxGen
News Release - March 27, 2007
Eve Slater to Resign From VaxGen's Board After Accepting Management Position at Leading Pharmaceutical Firm
SOUTH SAN FRANCISCO, Calif., March 27 (HSMN NewsFeed) -- VaxGen, Inc. (Pink Sheets: VXGN.PK ) announced today that Eve E. Slater, M.D., F.A.C.C, will resign from the company's Board of Directors as a result of having accepted a management position at a globally recognized pharmaceutical company. That company's employment policy requires that she relinquish all of her directorships.Dr. Slater is expected to remain on VaxGen's Board of Directors until August 1, 2007 or until the company recruits her replacement, whichever comes first. The recruitment process is already underway.
"On behalf of VaxGen's directors and officers, I want to thank Eve for her service to the company and its stockholders and for her extra commitment to remain with VaxGen while we undertake the search for her replacement," said Randall L-W. Caudill, VaxGen's Chairman. "We are pleased that she has been given this tremendous opportunity, and fully understand that it comes with an accompanying requirement that she resign her directorships. We wish her our very best and know that she will be a tremendous asset to her new employer."
Dr. Slater is a former executive with Merck Research Laboratories and more recently served as the Assistant Secretary for Health for the U.S. Department of Health and Human Services (HHS).
VaxGen is a biopharmaceutical company based in Brisbane, California. For more information, please visit the company's web site at www.VaxGen.com.
Source: VaxGen
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!